Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors

Chemistry and Biology

Volumn 6, Issue 6, 1999, Pages 361-375

  Young Tae, Chang ^a   Gray, Nathanael S ^a   Rosania, Gustavo R ^a   Sutherlin, Daniel P ^a   Kwon, Soojin ^a   Norman, Thea C ^a   Sarohia, Radhika ^a   Leost, Maryse ^b   Meijer, Laurent ^b   Schultz, Peter G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STATION BIOLOGIQUE   (France)

Author keywords

2,6,9 trisubstituted purine library; Apoptosis; CDK inhibitor; Cell based assay; Cell cycle arrest

Indexed keywords

EID: 0033150476     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80048-9     Document Type: Article

References (21)

1. Hodges, P.E. (ed). Yeast Proteome Handbook (1998, 5th ed.), Proteome, Inc., Beverly, USA.
2. Vesely, J., et al., & Meijer, L. (1994). Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224, 771-786.
3. Meijer, L. et al., & Moulinoux, J.-P. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536.
4. Schulze-Gahmen, U. et al., & Kim, S.-H. (1995). Multiple modes of ligand recognition - Crystal structure of cyclin dependent protein kinase 2 in complexes with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins 22, 378-391.
5. Nigg, E.A. (1995). Cyclin-dependent protein kinases - Key regulators of the eukaryotic cell cycle. BioEssays 17, 471-480.
6. Norman, T.C., Gray, N.S., Koh, J.T. & Schultz, P.G. (1996). A structure-based library approach to kinase inhibitors. J. Am. Chem. Soc. 118, 7430-7431.
7. Gray, N.S., Kwon, S. & Schultz, P.G. (1997). Combinatorial synthesis of 2,9-substituted purines. Tetrahedron Lett. 38, 1161-1164.
8. Nugiel, D.A., Cornelius, L.A.M. & Corbett, J.W. (1997). Facile preparation of 2,6-disubstituted purines using solid-phase chemistry. J. Org. Chem. 62, 201-203.
9. Legraverend, M., Ludwig, O., Bisagni, E., Leclerc, S. & Meijer, L. (1998). Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases. Bioorg. Med. Chem. Lett. 8, 793-798.
10. Schow, S.R., et al., & Lum, R.T. (1997). Synthesis and activity of 2,6,9-trisubsituted purines. Bioorg. Med. Chem. Lett. 7, 2697-2702.
11. Fiorini, M.T. & Abell, C. (1998). Solution-phase synthesis of 2,6,9-trisubstituted purines. Tetrahedron Lett. 39, 1827-1830.
12. de Azevedo, Jr., W.F., Mueller-Diechmann, H.-J., Schulze-Gahmen, U., Worland, P.J., Sausville, E. & Kim, S.-H. (1996). Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl Acad. Sci. USA 93, 2735-2740.
13. Lawrie, A.M., Noble, M.E.M., Tunnah, P., Brown, N.R., Johnson, L.N. & Endicott, J.A. (1997). Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat. Struct. Biol. 4, 796-801.
14. Toyota, A., Katagiri, N. & Kaneko, C. (1993). The alkylation of 2-amino-6-chloropurine with alcohols by Mitsunobu reaction for a synthesis of carbocyclic guanosine analogs. Heterocycle 36, 1625-1630.
15. Legraverend, M., et al., & Fovaudon, V. (1999). Bioorg. Med. Chem., in press.
16. Gray, N.S., et al., & Schultz, P.G. (1998). Exploiting chemical libraries, structure and genomics in the search for kinase inhibitors. Science 281, 533-538.
17. Hansen, M.B., Nielsen, S.E. & Berg, K.J. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Immunol. Methods 119, 203-210.
18. Guadagno, T.M. & Newport, J.W. (1996). CDK2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinase activity. Cell 84, 73-82.
19. Hinchliffe, E.H., Cassels, G.O., Rieder, C.L & Sluder, G. (1998). The coordination of centrosome reproduction with nuclear events of the cell cycle in the sea urchin zygote. J. Cell Biol. 140, 1417-1426.
20. Schutte, B., Nieland, L., van Engeland, M., Henfling, M.E.R., Meijer, L. & Ramaekers, F.C.S. (1997). The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. Exp. Cell Res. 236, 4-15.
21. Planchais, S. et al., & Bergounioux, C. (1997). Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension. Plant J. 12, 191-202.